↓ Skip to main content

A comparison of the ability of rilpivirine (TMC278) and selected analogues to inhibit clinically relevant HIV-1 reverse transcriptase mutants

Overview of attention for article published in Retrovirology, December 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

patent
14 patents

Citations

dimensions_citation
30 Dimensions

Readers on

mendeley
34 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A comparison of the ability of rilpivirine (TMC278) and selected analogues to inhibit clinically relevant HIV-1 reverse transcriptase mutants
Published in
Retrovirology, December 2012
DOI 10.1186/1742-4690-9-99
Pubmed ID
Authors

Barry C Johnson, Gary T Pauly, Ganesha Rai, Disha Patel, Joseph D Bauman, Heather L Baker, Kalyan Das, Joel P Schneider, David J Maloney, Eddy Arnold, Craig J Thomas, Stephen H Hughes

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 34 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Kenya 1 3%
Unknown 33 97%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 6 18%
Researcher 6 18%
Student > Bachelor 4 12%
Professor 3 9%
Student > Master 3 9%
Other 6 18%
Unknown 6 18%
Readers by discipline Count As %
Medicine and Dentistry 8 24%
Chemistry 8 24%
Biochemistry, Genetics and Molecular Biology 4 12%
Engineering 2 6%
Agricultural and Biological Sciences 2 6%
Other 3 9%
Unknown 7 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 January 2024.
All research outputs
#2,091,304
of 23,563,389 outputs
Outputs from Retrovirology
#87
of 1,118 outputs
Outputs of similar age
#20,113
of 282,091 outputs
Outputs of similar age from Retrovirology
#4
of 17 outputs
Altmetric has tracked 23,563,389 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,118 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 282,091 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 17 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.